ANDREA MCLIN: Open Payments
NPI 1780992263 · SAGINAW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 188 payments from 21 companies in 2025. Trend: 2023 $2,336 · 2024 $3,240 · 2025 $3,077
Food & beverage: $3,077
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 42 | $459 |
| ABBVIE INC. | 16 | $284 |
| GENZYME CORPORATION | 13 | $280 |
| Galderma Laboratories, L.P. | 13 | $206 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $206 |
| UCB, Inc. | 12 | $195 |
| MERZ NORTH AMERICA, INC. | 2 | $170 |
| PFIZER INC. | 10 | $169 |
| Regeneron Healthcare Solutions, Inc. | 13 | $162 |
| Organon LLC | 15 | $162 |
Products named: Zoryve, DUPIXENT, RINVOQ, Bimzelx, Xeomin, CIBINQO, NEMLUVIO, OPZELURA.
Industry payments across TX — which companies pay providers there.
